REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Acepodia,Inc (英属开曼群岛商育世博股份有限公司) (Taiwan, China)

Main Activities: Research and Development in Nanotechnology
Full name: Acepodia,Inc Profile Updated: October 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Acepodia,Inc is engaged in the research and development of immunotherapy of new generation cell drugs, targeting solid tumors and blood cancers. The company's main products include new cell drug preparations. The company was established in 2017 and is headquartered in New Taipei City, Taiwan.

Headquarters
12F. No.508, Sec.7 Zhongxiao E. Rd., Nangang Dist
Taipei City; Taipei City;

Contact Details: Purchase the Acepodia,Inc (英属开曼群岛商育世博股份有限公司) report to view the information.

Website: http://www.acepodia.com

Basic Information
Outstanding Shares:
Purchase the Acepodia,Inc (英属开曼群岛商育世博股份有限公司) report to view the information.
Financial Auditors:
Purchase the Acepodia,Inc (英属开曼群岛商育世博股份有限公司) report to view the information.
Incorporation Date:
February 15, 2017
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
36.95%
Purchase this report to view the information.
3.99%
Purchase this report to view the information.
3.51%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Acepodia Biotech,Inc. (United States)
100%
育世博生物科技股份有限公司
100%
Company Performance
Financial values in the chart are available after Acepodia,Inc (英属开曼群岛商育世博股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-40.51%▼
Total operating revenue
2208.86%▲
Operating profit (EBIT)
-39.19%▼
EBITDA
-34.64%▼
Net Profit (Loss) for the Period
-87.52%▼
Total assets
-16.98%▼
Total equity
-17.59%▼
Operating Profit Margin (ROS)
-133680.97%▼
Net Profit Margin
-125580.41%▼
Return on Equity (ROE)
-3.52%▼
Debt to Equity Ratio
0.16%▲
Quick Ratio
-20.55%▼
Cash Ratio
-20.76%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo